Epidermolysis Bullosa Simplex
Authors:
Open Access
- 24 December 2021
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of the Dermatology Nurses' Association
- Vol. 14 (1) , 16-19
Abstract
Epidermolysis bullosa simplex (EBS) is a rare autosomal dominant, genetic condition where bullous lesions, larger than 0.5 cm, affect an area of the skin that is exposed to mechanical friction or minor trauma. Prevention of the bullous lesions starts with family and patient education, with infants requiring greater care and control of their environment. Every individual with EBS will have a treatment plan specifically tailored to the severity and extent of skin involvement. This article provides a comprehensive overview of EBS, including diagnostic approach, preventative considerations, and current treatments.Keywords
This publication has 9 references indexed in Scilit:
- Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020Molecular Diagnosis & Therapy, 2020
- The challenges of living with and managing epidermolysis bullosa: insights from patients and caregiversOrphanet Journal of Rare Diseases, 2020
- Epidermolysis bullosa: Advances in research and treatmentExperimental Dermatology, 2019
- Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosaBritish Journal of Dermatology, 2019
- EB2017—Progress in Epidermolysis Bullosa Research toward Treatment and CureJournal of Investigative Dermatology, 2018
- Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplexOrphanet Journal of Rare Diseases, 2017
- Diagnosis, treatment and management of epidermolysis bullosaBritish Journal of Nursing, 2016
- Epidermolysis Bullosa and Chronic WoundsAdvances in Skin & Wound Care, 2013
- Updated systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosaClinical and Experimental Dermatology, 2012